Thromboprophylaxis for children hospitalized with COVID‐19 and MIS
Por um escritor misterioso
Descrição
How we approach thrombosis risk in children with COVID-19 infection - Authorea
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C - Schmitz - 2022 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library
Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3 - Henderson - 2022 - Arthritis & Rheumatology - Wiley Online Library
Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry - Canadian Journal of Cardiology
Multisystem inflammatory syndrome in children: another COVID-19 sequel, Cardiology in the Young
SciELO - Brasil - Proposed recommendations for antithrombotic prophylaxis for children and adolescents with severe infection and/or multisystem inflammatory syndrome caused by SARS-CoV-2 Proposed recommendations for antithrombotic prophylaxis for
MIS-C Associated with COVID-19 Anti-thrombosis Guideline of Care for Children - Advanced Cardiac Therapies Improving Outcomes Network
Thromboprophylaxis for Coagulopathy Related to COVID-19 in Pediatrics: A Narrative Review
Management of Multisystem Inflammatory Syndrome in Children Associated With COVID-19: A Survey From the International Kawasaki Disease Registry - ScienceDirect
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID -19 — COVID-NET, 14 States, March 2020–February 2022
